Eversept Partners, LP Cidara Therapeutics, Inc. Transaction History

Eversept Partners, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 14, 2018	SELL	$4.0 - $8.15 $200,000 - $407,500	-50,000 Closed	0 $0
Q4 2017 Nov 08, 2023	BUY	$6.35 - $8.75 $317,500 - $437,500	50,000 New	50,000 $340 Million
Q4 2017 Feb 12, 2018	BUY	$6.35 - $8.75 $317,500 - $437,500	50,000	50,000 $340,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.24B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.